Whenever you need heart rate and rhythm information, KardiaMobile 6L helps you get the clarity you need quickly and easily. With wide-ranging use cases from detecting atrial fibrillation to supporting clinical research and beyond, KardiaMobile 6L is trusted by leading cardiologists, top biopharma companies, large CROs, Fortune 100 employers, and major healthcare systems.
The first FDA-cleared, 6-lead personal ECG device.
In just 30 seconds, KardiaMobile 6L provides access to a high-quality, 6-lead ECG without the hassle of wires, patches, or gels – making it easy for patients in the home or the office.
Ideal for capturing a quick ECG at an office visit or for extended remote monitoring, the easy-to-use KardiaMobile 6L provides flexibility to diagnose and treat patients.
The world’s leading cardiologists use KardiaMobile, the most clinically validated personal ECG brand with over 185 clinical publications. Learn how KardiaMobile 6L can help you better treat your patients.
Atrial Fibrillation
Post-TAVR Monitoring
Smartwatches
Founder and Director Scripps Research Translational Institute, and author of the new book, Deep Medicine
Dr. Topol has no financial relationship with or research support from AliveCor.
Explore how AliveCor's digital health solutions can transform cardiovascular care.
Legal
KardiaMobile 6L is not tested or recommended for use with pacemakers and ICDs. KardiaMobile 6L does not check for heart attack.
For compatibility information, visit alivecor.com/compatibility.
1. De Lucia R, et al. Europace (2023) 25, 116-1125.
2. Wong KC et al. Heart. 2020 Aug;106(16):1211-1217.
3. Halcox, JPJ et al. Circulation vol. 136,19 (2017): 1784-1794.
4. Woosley RL, Heise CW, Gallo T, Woosley D and Romero KA, www.CredibleMeds.org, QTdrugs
5. J et al. Am Heart J. 2022 Nov;253:53-58.
